Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × OTHER_GOV × Interleukin-2 × Clear all

Phase

Status

Not yet recruiting 4 Recruiting 2 Withdrawn 1 Unknown 1 Completed 1

Sponsor Class

OTHER 87 NIH 32 INDUSTRY 10 NETWORK 3 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Melanoma 1

Interventions

Gemcitabine 14 Radiotherapy 10 Cisplatin 10 Metformin 8 Paclitaxel 7 Fluorouracil 7 Oxaliplatin 6 Indocyanine Green 6 Exercise 6 Docetaxel 6 Control Groups 6 Capecitabine 6 Surveys and Questionnaires 5 Standard of Care 5 Letrozole 5 Cyclophosphamide 5 Zoledronic Acid 4 Vinorelbine 4 Saline Solution 4 Preoperative Exercise 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 Irinotecan 4 Ifosfamide 4 Gefitinib 4 Drug Therapy 4 Carboplatin 4 pembrolizumab 3 Trastuzumab 3 Tranexamic Acid 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04812470 2025-09-22

HAITILS

Vastra Gotaland Region

Phase 1 Completed

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡